Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Other financing activities (2017)

Historic Other financing activities for Amicus Therapeutics (FOLD) over the last 4 years, with Q4 2017 value amounting to $23.1 million.

  • Amicus Therapeutics' Other financing activities changed N/A to $23.1 million in Q4 2017 from the same period last year, while for Sep 2018 it was $23.1 million, marking a year-over-year increase of 1661956.52%. This contributed to the annual value of $23.1 million for FY2017, which is 3197.55% up from last year.
  • Amicus Therapeutics' Other financing activities amounted to $23.1 million in Q4 2017.
  • Amicus Therapeutics' Other financing activities' 5-year high stood at $23.1 million during Q4 2017, with a 5-year trough of $28000.0 in Q1 2017.
  • Over the past 3 years, Amicus Therapeutics' median Other financing activities value was $110000.0 (recorded in 2013), while the average stood at $5.8 million.